Asia´s collagen market and demand to be discussed in Singapore conference

KUALA LUMPUR, Aug 21 (Bernama) -- BioCell Technology International GmbH to highlight on Asia’s collagen market and consumers’ demanding quality and scientific substantiation at Vitafoods Asia on September 11 to 12 in Singapore.

An overview of this growing body of research will be presented at Vitafoods Asia by scientific manager of Sochim International, Dr Vincenzo Boldrini which performs clinical evaluations of the efficacy of health and nutrition products.

The company’s unique -- BioCell Collagen -- is a highly bioavailable naturally occurring matrix of Hydrolyzed Type II collagen, chondroitin sulfate and hyaluronic acid which multiple human clinical studies have demonstrated its benefits for joint health and skin beauty.

Collagen is long established as an ingredient in Asia’s beauty from within market and its benefits for joint health add to its appeal for the region’s consumers, for whom healthy aging is an increasingly important goal,  a statement said.

A study on 80 people show that the BioCell Collagen was confirmed safe and effective compared to a placebo group, significantly promoted joint comfort and mobility as results corroborated an earlier trial found that it promoted joint comfort by as much as 40 per cent.

It also proven benefits for healthy aging and beauty which one study found that daily ingestion of BioCell Collagen for 12 weeks led to a 13 per cent reduction in wrinkles and a 76 per cent reduction in dryness and skin scaling.

BioCell Collagen is available in a Halal version certified to Malaysian Standard 1500 (MS 1500) by the Halal Quality Control/ Halal Certification Germany -- most developed Halal certification program in the world and provides a benchmark for Halal schemes globally.

BioCell Technology is a research, product development, branding, and marketing company that manufactures innovative and science-based raw material ingredients for applications in dietary supplements, functional foods and cosmetics. More details at www.BioCellTechnology.com.

-- BERNAMA